Cleared Traditional

K221419 - TD-5010 Lancing Device and TD-5084 Sterile Lancets (FDA 510(k) Clearance)

Jan 2023
Decision
249d
Days
Class 2
Risk

K221419 is an FDA 510(k) clearance for the TD-5010 Lancing Device and TD-5084 Sterile Lancets. This device is classified as a Multiple Use Blood Lancet For Single Patient Use Only (Class II - Special Controls, product code QRL).

Submitted by Gostar Co., Ltd. (New Taipei City, TW). The FDA issued a Cleared decision on January 20, 2023, 249 days after receiving the submission on May 16, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes..

Submission Details

510(k) Number K221419 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 2022
Decision Date January 20, 2023
Days to Decision 249 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QRL - Multiple Use Blood Lancet For Single Patient Use Only
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.